VHL and neoplasm: VHL/HIF-1α is a common signaling pathway in KIRC, and mutational inactivation of VHL leads to overexpression of HIF-1α in KIRC, inducing a tumor hypoxic microenvironment that is associated with poorer tumor-specific survival (53).